New and emerging treatments for symptomatic tardive dyskinesia
about
Second-generation antipsychotics and extrapyramidal adverse effectsEffect of Clonazepam Co-Administered with Clozapine on the Serum Clozapine and Norclozapine Concentration of Patients with Schizophrenia: A Retrospective Survey.Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases.Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.Identification and management of tardive dyskinesia: A case series and literature review.Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.Valbenazine for the treatment of tardive dyskinesia.Valbenazine granted breakthrough drug status for treating tardive dyskinesia.Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system.Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary MovementInterdisciplinary recognizing and managing of drug-induced tardive oromandibular dystonia: two case reports
P2860
Q21284676-9D19A27A-0424-4E51-9340-F04E2255E4BEQ33695827-FF1DB65F-0F06-4A68-B64E-54445D2BA1B4Q33714619-64C18083-151A-4DF7-9BE9-13B02317939CQ34693244-22CCB21D-EEE5-43D9-9686-72FDDFAB6BF1Q38306593-661F15FD-7B9A-4D7D-8095-EC4B74044B05Q38545655-F9E1385D-A643-49B0-AB6A-DEE2ACAE6F4DQ38555637-98554D5C-0EBD-453D-85AC-FF12F851396AQ38661066-585612DB-2E1C-46F6-83E6-F72CA2110F04Q38819771-D9769224-9C32-4BC8-9BB8-D74343D08C2EQ47105526-9C528BFB-872E-4040-9BE2-9F63213A1C99Q47225742-391EC792-5617-4E13-AA4A-14F69A8AF70DQ47346313-A4C89A0B-085B-4B8E-A0E7-A305D5010638Q47670227-4AC8365B-A418-418B-9065-18D164073AEFQ48088881-700965A6-0E81-49DA-A107-BCE0ED23D93DQ48624653-29C46EA4-A554-4B27-B636-A1E1C2352064Q55256658-1C2B4EB2-BB18-4643-AC51-AA4CC78E5751Q58701333-80D041AA-A9FE-4750-BD56-90FE38CC7E9CQ59136959-D47D6BC5-C7A3-4F3A-9F73-8456DB18236C
P2860
New and emerging treatments for symptomatic tardive dyskinesia
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New and emerging treatments for symptomatic tardive dyskinesia
@ast
New and emerging treatments for symptomatic tardive dyskinesia
@en
New and emerging treatments for symptomatic tardive dyskinesia
@nl
type
label
New and emerging treatments for symptomatic tardive dyskinesia
@ast
New and emerging treatments for symptomatic tardive dyskinesia
@en
New and emerging treatments for symptomatic tardive dyskinesia
@nl
prefLabel
New and emerging treatments for symptomatic tardive dyskinesia
@ast
New and emerging treatments for symptomatic tardive dyskinesia
@en
New and emerging treatments for symptomatic tardive dyskinesia
@nl
P2093
P2860
P921
P356
P1476
New and emerging treatments for symptomatic tardive dyskinesia
@en
P2093
Abdul Qayyum Rana
Pierre J Blanchet
Zishan M Chaudry
P2860
P304
P356
10.2147/DDDT.S32328
P407
P5008
P577
2013-11-06T00:00:00Z